v3.26.3
AGREEMENTS - Schedule of Expense Payments and Related Reimbursement Payments (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2025
Sep. 30, 2026
Aug. 31, 2026
Jul. 31, 2026
Jun. 30, 2026
May 31, 2026
Apr. 30, 2026
Mar. 31, 2026
Feb. 28, 2026
Jan. 31, 2026
Dec. 31, 2025
Nov. 30, 2025
Oct. 31, 2025
Sep. 30, 2025
Aug. 31, 2025
Jul. 31, 2025
Jun. 30, 2025
May 31, 2025
Apr. 30, 2025
Mar. 31, 2025
Feb. 28, 2025
Dec. 31, 2024
Nov. 30, 2024
Oct. 31, 2024
Sep. 30, 2024
Aug. 31, 2024
Jul. 31, 2024
Jun. 30, 2024
May 31, 2024
Apr. 30, 2024
Mar. 31, 2024
Feb. 29, 2024
Jan. 31, 2024
Dec. 31, 2023
Nov. 30, 2023
Oct. 31, 2023
Sep. 30, 2023
Aug. 31, 2023
Jul. 31, 2023
Jun. 30, 2023
May 31, 2023
Apr. 30, 2023
Mar. 31, 2023
Feb. 28, 2023
Jan. 31, 2023
Dec. 31, 2022
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Investment Company, Financial Highlights [Line Items]                                                                                                    
Expense Support from the Adviser                                                                                             $ 0 $ 15,363 $ 8,633 $ 45,915
Expense Support Reimbursed to the Adviser                                                                                             38,940 4,516 54,576 7,400
Expense Support and Conditional Reimbursement Agreement | Affiliated Entity                                                                                                    
Investment Company, Financial Highlights [Line Items]                                                                                                    
Expense Support from the Adviser $ 0 $ 0 $ 0 $ 0 $ 0 $ 8,633 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 9,708 $ 0 $ 5,655 $ 5,853 $ 4,915 $ 9,348 $ 10,436 $ 0 $ 3,736 $ 3,911 $ 3,598 $ 5,402 $ 4,291 $ 1,164 $ 3,170 $ 2,437 $ 3,066 $ 2,194 $ 2,183 $ 1,592 $ 1,144 $ 1,637 $ 0 $ 1,636 $ 2,300 $ 2,502 $ 2,253 $ 1,312 $ 1,083 $ 916 $ 891 $ 1,088 $ 1,449        
Base Management Fee and Income Based Fee Waived 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (1,132) (727) (569) (458) (144) (216) (398) (129)        
Expense Support Reimbursed to the Adviser 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (5,853) (274) (9,348) (10,436) 0 (3,736) (3,911) (3,598) (5,402) (4,291) (1,164) (3,170) (2,437) (3,066) (2,194) (2,183) (1,592) (1,144) (1,637) 0 (1,636) (2,300) (1,370) (1,526) (743) (625) (772) (675) (690) (1,320)        
Expense Support No Longer Eligible for Reimbursement 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0        
Unreimbursed Expense Support $ 0 $ 0 $ 0 $ 0 $ 0 $ 8,633 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 9,708 $ 0 $ 5,655 $ 0 $ 4,641 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 9,708 $ 0 $ 9,708
Ratio of Operating Expense to Average Net Assets for the Period 0.23% 0.25% 0.33% 0.30% 0.33% 0.32% 0.29% 0.32% 0.33% 0.27% 0.34% 0.24% 0.23% 0.26% 0.24% 0.26% 0.36% 0.27% 0.30% 0.29% 0.28% 0.25% 0.36% 0.30% 0.36% 0.33% 0.32% 0.46% 0.45% 0.49% 0.76% 0.47% 0.55% 0.45% 0.53% 0.47% 0.80% 0.98% 0.77% 1.94% 1.77% 1.76% 2.28% 2.09% 2.54% 3.83%        
Annualized Distribution per Share 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.5716 2.3910 2.3910 2.3910 0 0 0 0 0 0 0 0